THE ROLE OF ISOCOLLOIDOOSMOTIC SYNTHETIC COLLOID ADDITION TO ST. THOMAS HOSPITAL CARDIOPLEGIC SOLUTION FOR CARDIOPROTECTION IN ISOLATED PERFUSED RAT HEARTS

Cardiac transplantation is a prominent development in the treatment of patients with severe cardiac diseases. If it is not possible to transplant the heart immediately after removing it from the donor, procedures for preparing, protecting, storing and transferring of the heart constitute a major por...

Full description

Saved in:

Bibliographic Details
Published in:	Pharmacological research Vol. 36; no. 1; pp. 9 - 15
Main Authors:	SÜ ZER, Ö NER, Dİ Rİ, ERDAL, KONUKOĞ LU, Dİ LDAR, Ö ZÜ NER, ZEKİ
Format:	Journal Article
Language:	English
Published:	Netherlands Elsevier Ltd 01-07-1997
Subjects:	Adenosine Triphosphate - metabolism Animals Bicarbonates - pharmacology Calcium Chloride - pharmacology cardiac protection cardioplegic solution Cardioplegic Solutions - pharmacology Colloids Coronary Circulation - drug effects Creatine Kinase - metabolism dextrans Female Gelatin gelatins Glutathione - metabolism Heart HES In Vitro Techniques L-Lactate Dehydrogenase - metabolism Magnesium - pharmacology Male Malondialdehyde - metabolism Myocardial Contraction - drug effects Myocardial Ischemia - metabolism Myocardial Reperfusion Myocardium - enzymology Myocardium - metabolism Organ Preservation - methods Potassium Chloride - pharmacology Rats Rats, Wistar Sodium Chloride - pharmacology St Thomas Hospital cardioplegic solution dextrans gelatins cardiac protection St Thomas Hospital HES
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Description
Summary:	Cardiac transplantation is a prominent development in the treatment of patients with severe cardiac diseases. If it is not possible to transplant the heart immediately after removing it from the donor, procedures for preparing, protecting, storing and transferring of the heart constitute a major portion of this study. Selecting the best method among those used for cardioprotection is still been debated. This experimental study investigated whether isocolloidoosmotic solution in addition to St. Thomas Hospital cardioplegic solution would give better cardioprotection. Wistar rat hearts were isolated and perfused by the Langendorff method (n=6 for each group). In the control group after stabilisation, the hearts were arrested while perfused with St. Thomas Hospital cardioplegic solution for 3 min, then they were placed in cardioplegic solution at 4°C for 6 h. Afterwards the hearts were reperfused. In the experimental groups, modified gelatin fluid (30 g/l) or HES 200/0.5 (50 g/l) or dextran 70 (25 g/l) was added to the cardioplegic solution. Maximum contractility, +dF/dtmax, −dF/dtmax, heart rate, contractility rate product, coronary flow and lactate dehydrogenase, creatine phosphokinase enzyme leakage were measured in all groups during pre-ischemic and post-ischemic periods (10 min after reperfusion). At the end of each experiment, the hearts were weighted and tissue levels of lipid peroxide, expressed in terms of thiobarbituric acid reactive substances, malondialdehyde, glutathione (an important intracellular antioxidant) and ATP were measured. Non-ischemic tissue levels of malondialdehyde, glutathione and ATP were also measured in another group (n=6). There was no statistically significant difference among the simultaneous experimental and control groups in any criteria evaluated (P>0.05). The addition of synthetic colloids to the standard cardioplegic solution did not provide further protection except for the gelatin group in which recovered contractile force was not significantly different from the group's initial values. This effect may be explained by its degradation to amino acids which may play a substrate role.
Bibliography:	ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23
ISSN:	1043-6618 1096-1186
DOI:	10.1006/phrs.1997.0206